IBDEI02K ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,648,1,3,0)
 ;;=3^Personal history of malignant neoplasm of nasl cav, mid ear, & acces sinus
 ;;^UTILITY(U,$J,358.3,648,1,4,0)
 ;;=4^Z85.22
 ;;^UTILITY(U,$J,358.3,648,2)
 ;;=^5063412
 ;;^UTILITY(U,$J,358.3,649,0)
 ;;=Z85.238^^2^27^17
 ;;^UTILITY(U,$J,358.3,649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,649,1,3,0)
 ;;=3^Personal history of malignant neoplasm of thymus NEC
 ;;^UTILITY(U,$J,358.3,649,1,4,0)
 ;;=4^Z85.238
 ;;^UTILITY(U,$J,358.3,649,2)
 ;;=^5063414
 ;;^UTILITY(U,$J,358.3,650,0)
 ;;=Z85.29^^2^27^18
 ;;^UTILITY(U,$J,358.3,650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,650,1,3,0)
 ;;=3^Personal history of malignant neoplasm of resp and intrathorac organs
 ;;^UTILITY(U,$J,358.3,650,1,4,0)
 ;;=4^Z85.29
 ;;^UTILITY(U,$J,358.3,650,2)
 ;;=^5063415
 ;;^UTILITY(U,$J,358.3,651,0)
 ;;=Z85.3^^2^27^19
 ;;^UTILITY(U,$J,358.3,651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,651,1,3,0)
 ;;=3^Personal history of malignant neoplasm of breast
 ;;^UTILITY(U,$J,358.3,651,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,651,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,652,0)
 ;;=Z85.41^^2^27^20
 ;;^UTILITY(U,$J,358.3,652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,652,1,3,0)
 ;;=3^Personal history of malignant neoplasm of cervix uteri
 ;;^UTILITY(U,$J,358.3,652,1,4,0)
 ;;=4^Z85.41
 ;;^UTILITY(U,$J,358.3,652,2)
 ;;=^5063418
 ;;^UTILITY(U,$J,358.3,653,0)
 ;;=Z85.43^^2^27^21
 ;;^UTILITY(U,$J,358.3,653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,653,1,3,0)
 ;;=3^Personal history of malignant neoplasm of ovary
 ;;^UTILITY(U,$J,358.3,653,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,653,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,654,0)
 ;;=Z85.44^^2^27^22
 ;;^UTILITY(U,$J,358.3,654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,654,1,3,0)
 ;;=3^Personal history of malignant neoplasm of female genital organs
 ;;^UTILITY(U,$J,358.3,654,1,4,0)
 ;;=4^Z85.44
 ;;^UTILITY(U,$J,358.3,654,2)
 ;;=^5063421
 ;;^UTILITY(U,$J,358.3,655,0)
 ;;=Z85.46^^2^27^23
 ;;^UTILITY(U,$J,358.3,655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,655,1,3,0)
 ;;=3^Personal history of malignant neoplasm of prostate
 ;;^UTILITY(U,$J,358.3,655,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,655,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,656,0)
 ;;=Z85.47^^2^27^24
 ;;^UTILITY(U,$J,358.3,656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,656,1,3,0)
 ;;=3^Personal history of malignant neoplasm of testis
 ;;^UTILITY(U,$J,358.3,656,1,4,0)
 ;;=4^Z85.47
 ;;^UTILITY(U,$J,358.3,656,2)
 ;;=^5063424
 ;;^UTILITY(U,$J,358.3,657,0)
 ;;=Z85.49^^2^27^25
 ;;^UTILITY(U,$J,358.3,657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,657,1,3,0)
 ;;=3^Personal history of malignant neoplasm of male genital organs
 ;;^UTILITY(U,$J,358.3,657,1,4,0)
 ;;=4^Z85.49
 ;;^UTILITY(U,$J,358.3,657,2)
 ;;=^5063426
 ;;^UTILITY(U,$J,358.3,658,0)
 ;;=Z85.51^^2^27^26
 ;;^UTILITY(U,$J,358.3,658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,658,1,3,0)
 ;;=3^Personal history of malignant neoplasm of bladder
 ;;^UTILITY(U,$J,358.3,658,1,4,0)
 ;;=4^Z85.51
 ;;^UTILITY(U,$J,358.3,658,2)
 ;;=^5063428
 ;;^UTILITY(U,$J,358.3,659,0)
 ;;=Z85.528^^2^27^27
 ;;^UTILITY(U,$J,358.3,659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,659,1,3,0)
 ;;=3^Personal history of malignant neoplasm of kidney NEC
 ;;^UTILITY(U,$J,358.3,659,1,4,0)
 ;;=4^Z85.528
 ;;^UTILITY(U,$J,358.3,659,2)
 ;;=^5063430
 ;;^UTILITY(U,$J,358.3,660,0)
 ;;=Z85.79^^2^27^28
 ;;^UTILITY(U,$J,358.3,660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,660,1,3,0)
 ;;=3^Personal history of malignant neoplasm of lymphoid, hematpoetc & rel tiss
 ;;^UTILITY(U,$J,358.3,660,1,4,0)
 ;;=4^Z85.79
 ;;
 ;;$END ROU IBDEI02K
